AstraZeneca plc vs Vipshop Holdings Ltd - ADR — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.20B). The key difference: AstraZeneca plc is far larger — about 34.5× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.14%). Which is the better fit depends on your goals.
| AZN | VIPS | |
|---|---|---|
Market Cap | $248.14B | $7.20B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $20.68 |
52-Week Low | $147.06 | $12.92 |
Enterprise Value | $275.41B | $3.76B |
Dividend Yield | 2.01% | 4.14% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →